Arthur (Skip) Colvin is a senior technical executive and serial entrepreneur with a consistent 35+ year record of technical innovation and successful leadership of entrepreneurial product creation and development programs. Colvin has been directly responsible for more than 40 successful products in life science and medical technology from concept to commercialization, and has served in corporate positions ranging from Chief Scientist to CEO.

A graduate of Virginia Polytechnic Institute, Colvin began his career at the startup of Life Technologies (then BRL) while a part time graduate student both at Johns Hopkins APL and the University of Maryland Department of Chemical Engineering. Colvin later founded Cerex Corporation designing and developing products, technologies, and processes for clients as diverse as NIH, Anheuser Busch, the Steeltin Can Corporation, Eli Lilly, Kontes Scientific, New Brunswick Scientific, WR Grace, the National Food Processors, NASA, Life Technologies, Kirkegaard and Perry Laboratories and others.

Most recently Colvin co-founded Sensors for Medicine and Science (now Senseonics) serving as chief scientist to create, design and develop the first ever fully implantable wireless long-term human continuous glucose monitoring system for people with diabetes and helped to raise more than $100 million dollars in venture capital financing. Colvin now has more than 70 U.S. patents, including both issued and pending with approximately 300 foreign counterparts.